A recent analysis suggests that the black box warnings added to antidepressant medications due to an increased risk of suicidality may have resulted in negative consequences, including a decline in mental health treatment and an increase in suicide attempts and deaths among young people. The warnings, which were implemented by the FDA in 2005 and expanded in 2007, were intended to increase monitoring of patients on antidepressants, but the study found that this did not happen. Instead, there were abrupt declines in doctor visits for depression, antidepressant use, and increases in suicide attempts and deaths after the warnings were issued. These findings have raised concerns about the potential harms of the warnings outweighing the benefits.
Source link
FDA Antidepressant Warnings Tied to Increase in Suicidality
